Practice 17 structured short- and long-answer medical questions on Respiratory Pathology 1b. Review model answers for exam revision.
Answer: This article provides a high-yield overview of frequently tested yet often "missed" topics in respiratory pathology, designed to complement a broader study of the respiratory system. It covers eleven distinct areas, ranging from immunologically mediated lung diseases like hypersensitivity pneumonitis and pulmonary eosinophilia, to smoking-related interstitial diseases, and lung involvement in systemic conditions like collagen vascular disease and Wegener granulomatosis. The content also delves into specific causes of pulmonary disease such as drug/radiation-induced injury, idiopathic pulmonary hemosiderosis, and various nonthrombotic pulmonary emboli. Finally, it details the pathology of neuroendocrine tumors like carcinoid, the aggressive malignant mesothelioma, and key chronic fungal pneumonias (histoplasmosis, coccidioidomycosis, blastomycosis), concluding with a critical section on pneumonia in immunocompromised hosts, highlighting specific pathogens and their diagnostic features. The focus is on key distinctions, diagnostic markers, characteristic morphologies, and management principles, emphasizing points often tested in multiple-choice questions and clinical scenarios. It serves as a crucial resource for solidifying understanding of less common but important respiratory pathologies. ## Key Points - **Hypersensitivity Pneumonitis**: An immunologically mediated inflammatory lung disease affecting alveoli, often occupational, involving Type III and Type IV hypersensitivity. Key distinction from asthma is alveolar (not bronchial) injury. - **Pulmonary Eosinophilia**: A group of conditions characterized by eosinophil infiltration in the lung, often immunologic. Löffler Syndrome is transient and benign; Acute Eosinophilic Pneumonia responds well to corticosteroids. - **Smoking-Related Interstitial Diseases**: Desquamative Interstitial Pneumonia (DIP) and Respiratory Bronchiolitis (RB-ILD) are both caused by smoking, characterized by "smoker's macrophages," and generally have an excellent prognosis with smoking cessation. - **Collagen Vascular Disease (Lung Involvement)**: Many systemic autoimmune diseases can cause various pulmonary patterns (NSIP, UIP, vasculitis, pleural involvement), and lung involvement typically indicates a poor prognosis. Clinical context is crucial for diagnosis, especially with UIP patterns. - **Drug- and Radiation-Induced Pulmonary Disease**: Bleomycin and Amiodarone are known to cause pneumonitis and fibrosis. Radiation pneumonitis occurs 1-6 months post-therapy with infiltrates corresponding to the radiation field. - **Idiopathic Pulmonary Hemosiderosis**: A rare disease with pulmonary manifestations similar to Goodpasture syndrome (hemoptysis, anemia, infiltrates) but *without* renal disease or anti-GBM antibodies. - **Wegener Granulomatosis**: Characterized by necrotizing vasculitis and granulomatous inflammation in the lung, often with upper respiratory and renal involvement. Diagnostically linked to **c-ANCA (PR3-ANCA)** positivity. - **Carcinoid Tumors of the Lung**: Neuroendocrine tumors arising from Kulchitsky cells, less aggressive than SCLC. Classified as typical (low-grade, better prognosis) or atypical (intermediate-grade). Positive for neuroendocrine markers like chromogranin. - **Malignant Mesothelioma**: A primary pleural malignancy strongly linked to asbestos exposure, with a long latency period. Distinguished from adenocarcinoma by IHC markers (Calretinin+, CEA-, TTF-1-). Grim prognosis. - **Nonthrombotic Pulmonary Emboli**: Includes Fat Embolism (trauma, long bone fractures), Air Embolism (iatrogenic), Amniotic Fluid Embolism (catastrophic obstetric emergency), and Talc Embolism (IV drug abuse leading to granulomas and pulmonary hypertension). - **Chronic Fungal Pneumonias**: Histoplasmosis (Ohio/Mississippi valleys, yeast in macrophages), Coccidioidomycosis (SW USA, spherules with endospores), and Blastomycosis (N. America, broad-based budding yeast) are major causes of chronic granulomatous pneumonia, each with distinct geography and pathology. - **Pneumonia in Immunocompromised Host**: Key pathogens depend on the immune defect. PCP (Pneumocystis jiroveci) is common in AIDS (CD4 <200), characterized by foamy alveolar exudate. CMV shows "owl-eye" inclusions. Invasive Aspergillosis is angioinvasive with 45-degree branching hyphae. ## Detailed Notes ## EXAM BLUEPRINT FOR THESE TOPICS These are frequently tested as: "odd one out" MCQs, short definition questions, compare/contrast with main diseases, and clinical scenario SAQs. Don't underestimate them — examiners love the "smaller" topics. ## 1. HYPERSENSITIVITY PNEUMONITIS (ALLERGIC ALVEOLITIS) ### MUST KNOWS - **Definition:** Immunologically mediated inflammatory lung disease primarily affecting the **alveoli** (not bronchi like asthma) - Also called: **Allergic Alveolitis** - Most often an **occupational disease** from heightened sensitivity to inhaled antigens - Classic example: **Farmer's Lung** (moldy hay — thermophilic actinomycetes) - Manifests as predominantly **restrictive** lung disease with: - ↓ diffusion capacity - ↓ lung compliance - ↓ total lung volume **KEY DISTINCTION FROM ASTHMA:** - Asthma = bronchial injury - Hypersensitivity pneumonitis = **alveolar injury** **Common Occupational Examples:** | Disease | Antigen Source | | :---------------------- | :---------------------------------- | | Farmer's Lung | Moldy hay (thermophilic actinomycetes) | | Bird Fancier's Lung | Bird droppings/feathers | | Humidifier/Air-conditioner Lung | Contaminated water reservoirs | | Bagassosis | Moldy sugarcane | | Mushroom Worker's Lung | Mushroom compost | **Immunologic Mechanisms — ALL THREE involved:**
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: **Upper respiratory symptoms:** - Chronic sinusitis - Epistaxis - **Nasal perforation** (classic/pathognomonic feature) **Pulmonary symptoms:** - Cough - Hemoptysis - Chest pain **Serology:** - **PR3-ANCAs (c-ANCA)** present in **close to 95% of cases** — key diagnostic marker - PR3-ANCA = proteinase 3 antineutrophil cytoplasmic antibody **MCQ ANCHORS:** - Wegener = c-ANCA (PR3-ANCA) positive in 95% - Nasal perforation = classic Wegener feature - Both necrotizing vasculitis AND necrotizing granulomas in lung = Wegener ## 8. CARCINOID TUMORS OF THE LUNG ### MUST KNOWS - Neuroendocrine tumors of the lung - Represent **1–5% of all lung tumors** - Arise from **Kulchitsky cells** (neuroendocrine cells of bronchial epithelium) - **Less aggressive** than small cell carcinoma (also neuroendocrine) but malignant potential exists **Two types:** | Type | Features | | :------------------- | :------------------------------------------------------------------------------ | | **Typical Carcinoid** | Low-grade; <2 mitoses/10 HPF; no necrosis; better prognosis | | **Atypical Carcinoid** | Intermediate-grade; 2–10 mitoses/10 HPF; may have necrosis; worse prognosis | **Location:** - Most are **central** (main/lobar bronchi) — can cause bronchial obstruction - Minority are peripheral **Morphology:** - Well-circumscribed, highly vascular, pink-tan intrabronchial masses - Histology: uniform cells with **round nuclei, "salt and pepper" chromatin** (neuroendocrine appearance) - Cells arranged in nests, cords, trabeculae - **Positive for neuroendocrine markers:** chromogranin, synaptophysin, CD56, NSE **Clinical Features:** - Persistent cough, hemoptysis, recurrent pneumonia (from bronchial obstruction) - **Carcinoid syndrome** (rare with pulmonary carcinoids — more common with GI carcinoids): - Flushing, diarrhea, bronchospasm, right-sided cardiac lesions - Occurs when tumor secretes serotonin into systemic circulation (bypassing liver) - Pulmonary carcinoids drain into pulmonary veins → systemic circulation directly → can cause carcinoid syndrome even without liver metastases **Prognosis:** - Typical carcinoid: **>90% 5-year survival** after resection - Atypical carcinoid: 50–70% 5-year survival - Both far better than SCLC **MCQ TRAP:** Carcinoid is neuroendocrine like SCLC but FAR better prognosis. SCLC = aggressive, metastatic at presentation. Carcinoid = often curable by surgery. ## 9. MALIGNANT MESOTHELIOMA ### MUST KNOWS - Primary malignancy of the **pleura** (also peritoneum, pericardium) - **Strongly linked to asbestos exposure** - Normal incidence: **2–17 cases per 1 million persons** - Asbestos exposure: **>1000x increased risk** - Long latency period: typically **25–45 years** after asbestos exposure - Smoking does **NOT** increase mesothelioma risk (unlike lung carcinoma where smoking + asbestos = synergistic) - Amphibole asbestos (straight fibers) more carcinogenic for mesothelioma than chrysotile **Pathogenesis:** - Reactive free radicals generated by asbestos fibers → oncogenic effects on mesothelium - Asbestos fibers preferentially localize in distal lung close to mesothelial layer **Morphology:** - Begins as small nodules on pleural surface → sheets of tumor encasing the lung ("rind-like" encasement) - Three histologic patterns:
Answer: Model answer pending
Answer: Model answer pending
Answer: **Key Immunohistochemistry (distinguishing mesothelioma from adenocarcinoma):** | Marker | Mesothelioma | Adenocarcinoma | | :-------------- | :------------- | :---------------- | | Calretinin | **Positive** | Negative | | WT-1 | **Positive** | Negative | | D2-40 (podoplanin) | **Positive** | Negative | | CEA | Negative | **Positive** | | TTF-1 | Negative | **Positive** (lung primary) | | MOC-31 | Negative | **Positive** | **Clinical Features:** - Presents with **chest pain** + **recurrent pleural effusion** (often hemorrhagic) - Progressive dyspnea - CXR: pleural effusion + pleural thickening/nodularity - **Grim prognosis** — median survival **12–18 months** from diagnosis - Treatment: surgery (pleurectomy/extrapleural pneumonectomy) + chemotherapy (cisplatin + pemetrexed) + radiation; rarely curative **HIGH YIELD MCQ:** Mesothelioma vs adenocarcinoma on IHC — know calretinin (meso +), CEA (adeno +), TTF-1 (adeno +). ## 10. NONTHROMBOTIC PULMONARY EMBOLI ### MUST KNOWS **Fat Embolism:** - After **massive trauma** (long bone fractures) or bone infarction (sickle cell anemia) - Fat globules + bone marrow elements (hematopoietic + fat) enter circulation - **Fat embolism syndrome:** petechiae, neurologic symptoms, respiratory failure (24–72 hours after injury) - Mechanism: mechanical obstruction + toxic fatty acid release → endothelial damage **Air Embolism:** - From iatrogenic causes (IV lines, surgery, mechanical ventilation barotrauma) - Large air bolus → right heart outflow obstruction → cardiovascular collapse - "Mill wheel" murmur on auscultation **Amniotic Fluid Embolism:** - Rare but **catastrophic** obstetric emergency - Amniotic fluid enters maternal circulation during/after delivery - Features: sudden dyspnea + hypoxia + hypotension + DIC - High maternal mortality - Mechanism: squamous cells + fetal debris in amniotic fluid → pulmonary microvasculature → inflammatory response + coagulopathy **Talc Embolism (IV Drug Abuse):** - IV drug abuse → **magnesium trisilicate (talc)** in mixture → pulmonary microvasculature - Talc → **granulomatous response** (interstitium OR pulmonary arteries) - Interstitial involvement → **fibrosis** - Vascular involvement → **pulmonary hypertension** - **Residual talc crystals visible under polarized light** within granulomas **Bone Marrow Embolism:** - Haematopoietic + fat elements within pulmonary circulation - After massive trauma OR bone infarction in **sickle cell anemia** ## 11. CHRONIC PNEUMONIAS — FUNGAL ### MUST KNOWS **Three major fungi causing chronic granulomatous pneumonia:** ### Histoplasmosis - Organism: **Histoplasma capsulatum** - Geography: Mississippi/Ohio River valleys (USA); also endemic in Africa, Latin America - Reservoir: soil enriched with **bird/bat droppings** - Infection: inhalation of microconidia - Most infections: **asymptomatic** or mild flu-like illness - Pathology: **caseating granulomas** (can mimic TB) — Histoplasma identified within macrophages - Progressive disseminated histoplasmosis: immunocompromised patients - Diagnosis: culture, urinary antigen, serology, histology (GMS stain shows small yeast within macrophages) ### Coccidioidomycosis - Organism: **Coccidioides immitis** - Geography: **Southwestern USA** (San Joaquin Valley fever), also Mexico, Central/South America - Reservoir: dry/arid soil - Most infections: asymptomatic or self-limiting flu-like illness ("Valley Fever") - Pathology: **noncaseating or caseating granulomas**; characteristic **spherules** (large round structures containing endospores) — pathognomonic - Dissemination: rare but can affect meninges (most serious complication), skin, bone ### Blastomycosis - Organism: **Blastomyces dermatitidis** - Geography: **North America** (Mississippi/Ohio valleys + Great Lakes region) - Reservoir: soil - Primary pulmonary infection → can disseminate to **skin** (most common extrapulmonary site), bone, genitourinary tract, CNS - Pathology: **mixed suppurative and granulomatous** inflammation; thick-walled, broad-based budding yeast — pathognomonic - More likely to cause symptomatic/progressive disease than Histoplasma **Comparison Table:** | Feature | Histoplasmosis | Coccidioidomycosis | Blastomycosis | | :--------------------- | :------------------------ | :--------------------------- | :-------------------------------- | | Geography | Mississippi/Ohio valleys | SW USA (arid) | N. America (Ohio/Mississippi/Great Lakes) | | Pathology | Caseating granulomas; yeast in macrophages | Granulomas; **spherules** | Mixed suppurative + granulomatous; broad-based budding yeast | | Most common extrapulmonary | Liver, spleen, adrenals | **Meninges** (most serious) | **Skin** | | Immunocompromised risk | High (disseminated) | Moderate | Moderate | ## 12. PNEUMONIA IN IMMUNOCOMPROMISED HOST ### MUST KNOWS **Key pathogens by immune defect:** | Immune Defect | Key Pathogens | | :------------------------- | :----------------------------------------------------- | | Neutrophil defects | Gram-negative bacteria, S. aureus, **Aspergillus**, Candida | | Humoral (antibody) deficiency | Encapsulated bacteria (S. pneumoniae, H. influenzae) | | T cell deficiency (HIV, transplant) | **PCP (Pneumocystis jiroveci)**, CMV, MAC, Toxoplasma, Cryptococcus | | Combined (severe) | All of the above | ### Pneumocystis jiroveci Pneumonia (PCP) - Most common opportunistic infection in **AIDS** patients (CD4 <200 cells/µL) - Previously called P. carinii (reclassified) - Organism: fungus (previously classified as protozoan) - CXR: bilateral "**ground-glass**" perihilar infiltrates - BAL or induced sputum diagnosis: **silver stain (GMS/Grocott)** shows cysts; **Giemsa** shows intracystic bodies - Histology: **foamy/frothy intra-alveolar exudate** (honeycomb-like on H&E) + minimal inflammation - Treatment: **TMP-SMX (trimethoprim-sulfamethoxazole)** first line; prophylaxis when CD4 <200 ### Cytomegalovirus (CMV) Pneumonia - Most common viral pneumonia in immunocompromised (transplant recipients especially) - Histology: **"owl-eye" intranuclear inclusions** + smaller cytoplasmic inclusions in enlarged cells (**cytomegaly**) - Interstitial pneumonitis pattern - Treatment: **ganciclovir** ### Invasive Aspergillosis - Angioinvasive — invades blood vessels → hemorrhagic infarcts - CXR/CT: **"halo sign"** (ground-glass around nodule) + **"air-crescent sign"** (late finding) - Histology: septate hyphae branching at **45-degree angles** - Diagnosis: **galactomannan antigen** in serum/BAL; beta-D-glucan - Treatment: **voriconazole** (first line) ### Invasive Candidiasis - Hematogenous dissemination from gut/IV catheter - Histology: **pseudohyphae + yeast** (blastoconidia) - Budding yeast with pseudohyphae — distinguished from Aspergillus (which has true hyphae) **KEY HISTO DISTINCTION:** - Aspergillus: septate hyphae, 45° branching - Mucor/Rhizopus: non-septate (ribbon-like) hyphae, 90° branching (right-angle) - Candida: pseudohyphae + budding yeast - PCP: foamy alveolar exudate + GMS-positive cysts ## Practice Questions
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: **Summary: Type III + Type IV hypersensitivity combined** **Morphology:** - Acute + chronic forms share: **patchy mononuclear cell infiltrates** in pulmonary interstitium with **peribronchiolar accentuation** - Lymphocytes predominate + plasma cells + epithelioid cells - Acute form: variable neutrophils also present - **Interstitial noncaseating granulomas** in >2/3 of cases; usually **peribronchiolar location** - Advanced chronic: **diffuse interstitial fibrosis** **Clinical Features:** - **Acute form:** fever, cough, dyspnea, constitutional symptoms **4–8 hours after exposure** - Temporal relationship = key to diagnosis - Remove antigen → complete resolution within days - **Chronic form:** insidious onset — cough, dyspnea, malaise, weight loss - Failure to remove antigen → **irreversible chronic interstitial pulmonary disease** **HIGH YIELD:** If antigen NOT removed → irreversible fibrosis. This is the critical management point examiners test. ## 2. PULMONARY EOSINOPHILIA ### MUST KNOWS - Group of conditions characterized by **infiltration and activation of eosinophils** in the lung - Elevated alveolar **IL-5** drives eosinophil activation - Generally immunologic in origin; etiology often unknown **5 Categories:** ### 1. Acute Eosinophilic Pneumonia - Rapid onset: fever, dyspnea, hypoxia, diffuse pulmonary infiltrates on CXR - BAL fluid: **>25% eosinophils** - **Prompt response to corticosteroids** (dramatic improvement) ### 2. Simple Pulmonary Eosinophilia (Löffler Syndrome) - Transient pulmonary lesions + **blood eosinophilia** + **benign clinical course** - Alveolar septa thickened by eosinophils + occasional giant cells - Often self-limiting ### 3. Tropical Eosinophilia - Caused by infection with **microfilariae and helminthic parasites** - Endemic areas ### 4. Secondary Eosinophilia - Associated with: **asthma**, drug allergies, certain vasculitides ### 5. Idiopathic Chronic Eosinophilic Pneumonia - Aggregates of lymphocytes + eosinophils in septal walls + alveolar spaces - Characteristically in **periphery of lung fields** - Symptoms: high fever, night sweats, dyspnea - **Diagnosis of exclusion** (all other causes of pulmonary eosinophilia must be ruled out) **MCQ TRAP:** Löffler syndrome = simple eosinophilia + benign course + transient. Chronic eosinophilic pneumonia = peripheral distribution + high fever + diagnosis of exclusion. ## 3. SMOKING-RELATED INTERSTITIAL DISEASES ### MUST KNOWS Two related conditions — both from smoking, both restrictive: ### Desquamative Interstitial Pneumonia (DIP) - **Most striking histologic feature:** accumulation of large numbers of macrophages with **dusty-brown pigment ("smoker's macrophages")** in air spaces - Alveolar septa thickened by sparse lymphocytic infiltrate - Interstitial fibrosis: **mild when present** - Pulmonary function: **mild restrictive abnormality** - **Excellent prognosis** — good response to: - Steroid therapy - **Smoking cessation** The name "desquamative" is a misnomer — early pathologists thought the cells were desquamated epithelial cells; they are actually **macrophages**. ### Respiratory Bronchiolitis (RB-ILD) - Common histologic lesion in smokers - Pigmented intraluminal macrophages (same as DIP) but in **"bronchiolocentric" distribution** (first- and second-order respiratory bronchioles) - Mild **peribronchiolar fibrosis** - Presentation: gradual onset dyspnea + dry cough - Symptoms **recede with smoking cessation** **DIP vs RB-ILD comparison:** | Feature | DIP | RB-ILD | | :-------------------- | :---------------------- | :---------------------- | | Macrophage distribution | Diffuse air spaces | Bronchiolocentric | | Fibrosis | Mild | Mild peribronchiolar | | Treatment response | Steroids + smoking cessation | Smoking cessation | | Prognosis | Excellent | Good | ## 4. COLLAGEN VASCULAR DISEASE — LUNG INVOLVEMENT ### MUST KNOWS - Many collagen vascular diseases have pulmonary manifestations: - Systemic lupus erythematosus (SLE) - Rheumatoid arthritis (RA) - Systemic sclerosis (scleroderma) - Dermatomyositis-polymyositis **Histologic patterns seen (multiple possible in same patient):** - **NSIP pattern** (most common in systemic sclerosis) - **UIP pattern** (similar to IPF) - Vascular sclerosis - Organizing pneumonia (COP pattern) - Bronchiolitis (small airway disease ± fibrosis) - **Pleural involvement:** pleuritis, pleural nodules, pleural effusion **Prognosis:** - Pulmonary involvement = **poor prognosis** - Still better than IPF prognosis **KEY POINT for essays:** When you see UIP pattern on biopsy, always consider and exclude collagen vascular disease before diagnosing IPF. The histology is identical — clinical context matters. ## 5. DRUG- AND RADIATION-INDUCED PULMONARY DISEASE ### MUST KNOWS **Drug-Induced:** | Drug | Effect | | :-------------- | :------------------------------------------------------------- | | **Bleomycin** | Pneumonitis + interstitial fibrosis — direct drug toxicity + inflammatory cell influx into alveoli | | **Amiodarone** | Risk of pneumonitis + fibrosis | | **Methotrexate** | Hypersensitivity pneumonitis pattern | | **Nitrofurantoin** | Acute or chronic pulmonary reactions | **Radiation Pneumonitis:** - Complication of therapeutic irradiation of pulmonary/thoracic tumors - **Acute radiation pneumonitis:** - Occurs **1–6 months** after therapy - Up to **20% of patients** - Features: fever + dyspnea out of proportion to volume irradiated + pleural effusion + pulmonary infiltrates corresponding to radiation field - May resolve with **corticosteroid therapy** - **Chronic radiation pneumonitis:** - Progression from acute, or occurs independently - Associated with **pulmonary fibrosis** **Key MCQ:** Radiation pneumonitis occurs 1–6 months post-therapy, NOT immediately. The infiltrates correspond exactly to the radiation field — this is the diagnostic clue. ## 6. IDIOPATHIC PULMONARY HEMOSIDEROSIS ### MUST KNOWS - Rare disease of **uncertain etiology** - Pulmonary manifestations + histologic features **similar to Goodpasture syndrome** - **KEY DIFFERENCE from Goodpasture:** - **No associated renal disease** - **No circulating anti-basement membrane antibody** - Most cases occur in **children** (also reported in adults — adults have better prognosis) - Triad (same as other diffuse alveolar hemorrhage syndromes): **hemoptysis + anemia + diffuse pulmonary infiltrates** - Treatment: steroids + immunosuppressive therapy - Historical survival was only **2.5 years** — now markedly improved with therapy **Goodpasture vs Idiopathic Pulmonary Hemosiderosis — EXAM TABLE:** | Feature | Goodpasture | Idiopathic Pulmonary Hemosiderosis | | :---------------------- | :-------------------------------- | :---------------------------------- | | Renal involvement | YES (rapidly progressive GN) | NO | | Anti-GBM antibody | YES (>90%) | NO | | Linear IgG on biopsy | YES | NO | | Age | Young adults (men) | Children predominantly | | Treatment | Plasmapheresis + immunosuppression | Steroids + immunosuppression | ## 7. WEGENER GRANULOMATOSIS (PULMONARY ANGIITIS AND GRANULOMATOSIS) ### MUST KNOWS - **>80%** of Wegener granulomatosis (WG) patients develop upper respiratory or pulmonary manifestations - Classic triad: upper respiratory + lower respiratory + renal involvement **Lung lesions characterized by:**
Answer: Model answer pending